COPENHAGEN, Denmark, April 25, 2024 Ascendis Pharma A/S today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, after the.
COPENHAGEN, Denmark, April 03, 2023 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND) today announced that initial dose escalation data from the Company's ongoing Phase 1/2 IL-Believe Trial of TransCon
COPENHAGEN, Denmark, April 03, 2023 Ascendis Pharma A/S today announced that initial dose escalation data from the Company’s ongoing Phase 1/2 IL-Believe Trial of TransCon IL-2. | April 3, 2023
– On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 Ascendis Pharma A/S today. | January 8, 2023
Ascendis Pharma (ASND) Reports Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.